121 related articles for article (PubMed ID: 23238545)
1. Prothrombotic polymorphisms in patients with Raynaud's phenomenon and migraine.
Takáts AT; Shemirani AH; Zsóri KS; András C; Csiki Z
Acta Physiol Hung; 2012 Dec; 99(4):430-5. PubMed ID: 23238545
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of clotting factors in Hungarian patients with Raynaud's phenomenon.
Shemirani AH; Szomják E; Balogh E; András C; Kovács D; Acs J; Csiki Z
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):56-9. PubMed ID: 21157301
[TBL] [Abstract][Full Text] [Related]
3. Inherited prothrombotic risk factors in children with stroke, transient ischemic attack, or migraine.
Herak DC; Antolic MR; Krleza JL; Pavic M; Dodig S; Duranovic V; Brkic AB; Zadro R
Pediatrics; 2009 Apr; 123(4):e653-60. PubMed ID: 19336355
[TBL] [Abstract][Full Text] [Related]
4. Mutations in clotting factors and inflammatory bowel disease.
Bernstein CN; Sargent M; Vos HL; Rosendaal FR
Am J Gastroenterol; 2007 Feb; 102(2):338-43. PubMed ID: 17156138
[TBL] [Abstract][Full Text] [Related]
5. Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery.
Ozbek N; Ataç FB; Yildirim SV; Verdi H; Yazici C; Yilmaz BT; Tokel NK
Cardiol Young; 2005 Feb; 15(1):19-25. PubMed ID: 15831156
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and genetic risk factors for migraine in children.
Bottini F; Celle ME; Calevo MG; Amato S; Minniti G; Montaldi L; Di Pasquale D; Cerone R; Veneselli E; Molinari AC
Cephalalgia; 2006 Jun; 26(6):731-7. PubMed ID: 16686913
[TBL] [Abstract][Full Text] [Related]
8. Prothrombotic gene polymorphisms: possible contributors to hepatic artery thrombosis after orthotopic liver transplantation.
Pereboom IT; Adelmeijer J; van der Steege G; van den Berg AP; Lisman T; Porte RJ
Transplantation; 2011 Sep; 92(5):587-93. PubMed ID: 21836539
[TBL] [Abstract][Full Text] [Related]
9. The 3p21.1-p21.3 hereditary vascular retinopathy locus increases the risk for Raynaud's phenomenon and migraine.
Hottenga JJ; Vanmolkot KR; Kors EE; Kheradmand Kia S; de Jong PT; Haan J; Terwindt GM; Frants RR; Ferrari MD; van den Maagdenberg AM
Cephalalgia; 2005 Dec; 25(12):1168-72. PubMed ID: 16305605
[TBL] [Abstract][Full Text] [Related]
10. Genetic and acquired prothrombotic risk factors and sudden hearing loss.
Capaccio P; Ottaviani F; Cuccarini V; Bottero A; Schindler A; Cesana BM; Censuales S; Pignataro L
Laryngoscope; 2007 Mar; 117(3):547-51. PubMed ID: 17334320
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
Ozmen F; Ozmen MM; Ozalp N; Akar N
Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
Eid SS; Rihani G
Clin Lab Sci; 2004; 17(4):200-2. PubMed ID: 15559724
[TBL] [Abstract][Full Text] [Related]
13. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
Kim RJ; Becker RC
Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985
[TBL] [Abstract][Full Text] [Related]
14. The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals.
Supanc V; Sonicki Z; Vukasovic I; Solter VV; Zavoreo I; Kes VB
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e171-6. PubMed ID: 24189452
[TBL] [Abstract][Full Text] [Related]
15. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
Ben Salem-Berrabah O; Fekih-Mrissa N; N'siri B; Ben Hamida A; Benammar-Elgaaied A; Gritli N; Mrissa R
J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
[TBL] [Abstract][Full Text] [Related]
16. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
Eroglu A; Egin Y; Cam R; Akar N
Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
[TBL] [Abstract][Full Text] [Related]
17. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
18. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
Alhenc-Gelas M; Arnaud E; Nicaud V; Aubry ML; Fiessinger JN; Aiach M; Emmerich J
Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
